Gregory Hale

Human leucocyte antigen alloimmunization after bone marrow transplantation: an association with chronic myelogenous leukaemia.

Autologous stem cell transplantation for small cell lung cancer.

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses.

T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation.

Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients.

Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.

Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.

Allogeneic graft-versus-hepatoblastoma effect.

Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease.

Variations in working memory capacity predict individual differences in general learning abilities among genetically diverse mice.

Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome.

Autologous hematopoietic stem cell transplantation for pediatric solid tumors.

Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.

Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children.

EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantation.

Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.

Exploration in outbred mice covaries with general learning abilities irrespective of stress reactivity, emotionality, and physical attributes.

Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients.

Diagnostic challenge in recurrent skin rash after autologous bone marrow transplantation.

Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.

Establishing the use of body mass index as an indicator of nutrition risk in children with cancer.

Selective attention is a primary determinant of the relationship between working memory and general learning ability in outbred mice.

Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation.

CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.

Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research.

A novel approach for the analysis of T-cell reconstitution by using a T-cell receptor beta-based oligonucleotide microarray in hematopoietic stem cell transplantation.

Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic stem cell recipients receiving immunosuppressive therapy or with acute graft-versus-host disease: the St. Jude experience, 1990-2002.

A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation.

Pharmacological modulation of stress reactivity dissociates general learning ability from the propensity for exploration.

Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors.

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning.

High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors.

Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.

Molecular monitoring of immune reconstitution after haploidentical stem cell transplantation.

Leucoencephalopathy, transverse myelopathy, and peripheral neuropathy in association with glutamic acid decarboxylase-65 (GAD) antibodies in children with cancer.

Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation.

Up-regulation of exploratory tendencies does not enhance general learning abilities in juvenile or young-adult outbred mice.

Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.

Clinical and CT features of benign pneumatosis intestinalis in pediatric hematopoietic stem cell transplant and oncology patients.

Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.

HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens.

Advances in pediatric hematopoietic stem cell transplantation.

Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.

Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.

Total and active rabbit antithymocyte globulin (rATG;Thymoglobulin) pharmacokinetics in pediatric patients undergoing unrelated donor bone marrow transplantation.

Clinical utility of computed tomography screening of chest, abdomen, and sinuses before hematopoietic stem cell transplantation: the St. Jude experience.

Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.

影响结果的第二个 HLA 相合同胞捐助移植移植失败的严重的风险因素获得再生障碍性贫血。

Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.

Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.

Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residence.

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.

Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.

Deletion of PEA-15 in mice is associated with specific impairments of spatial learning abilities.

High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma.

A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.

Second unrelated donor hematopoietic cell transplantation for primary graft failure.

Perspective on the role of haploidentical transplantation in the management of hematologic malignancies: why do it?

Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.

One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.

Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia.

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors.

HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.

Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.

HLA-matched sibling bone marrow transplantation for β-thalassemia major.

Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study.

Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?

Clinical options after failure of allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.

Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations.

Outcomes of Allogeneic Hematopoietic Cell Transplantation for Adolescent and Young Adults Compared with Children and Older Adults with Acute Myeloid Leukemia.

Alternate Donor Hematopoietic Cell Transplantation (HCT) in Non-Hodgkin Lymphoma Using Lower Intensity Conditioning: A Report from the CIBMTR.

Outcome of Lower-Intensity Allogeneic Transplantation in Non-Hodgkin Lymphoma after Autologous Transplantation Failure.